India to Australia: Fluticasone Export Trade Route

The India to Australia Fluticasone corridor is one of India's established pharmaceutical export routes, with 152 shipments documented worth a combined $20.4M USD. The route is dominated by CIPLA LIMITED, which alone accounts for roughly 73% of all export value, reflecting the consolidated nature of India's fluticasone manufacturing sector.

Across 6 active suppliers, the average shipment value stands at $134.4K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 84% of all shipments, consistent with fluticasone's non-urgent bulk-order profile.

Shipment activity peaks during October–December, with an average transit time of 33 days port-to-port. The route has recorded an annual growth rate of 25.8%, placing it at rank #4 among India's top fluticasone export destinations globally.

On the import side, key buyers of Indian fluticasone in Australia include MYLAN AUSTRALIA, VIATRIS PTY LTD, SANDOZ PTY LTD and 19 others. MYLAN AUSTRALIA is the single largest importer with 34 shipments valued at $5.0M USD.

India's fluticasone exports to Australia are driven primarily by a handful of large-scale manufacturers. CIPLA LIMITED with 111 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 6 active exporters signals a competitive but concentrated market — buyers in Australia benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — CIPLA LIMITED, CIPLA LIMITED , GNH INDIA PHARMACEUTICALS LIMITED — together account for 100% of total trade value on this route. The average shipment value of $134.4K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as dymista azelastine hydrochloride 137mcg fluticasone propionate 50mcg per spray nasal suspension dymista trade pack and dymista azelastine hydrochloride 137mcg+fluticasone propionate 50mcg per spray nasal suspension;dymista trade pack -, suggesting that buyers in Australia tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, MYLAN AUSTRALIA is the largest importer with 34 shipments worth $5.0M USD — representing 24% of all fluticasone imports from India on this route. A total of 22 buyers are active on this corridor.